You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The firm said declines across most business areas were slightly offset by increases in sales of sample collection devices.
In PLOS this week: Aedes aegypti and Ae. albopictus mosquito population genomics, strategies to profile hepatitis viruses, and more.
If the proposal is finalized, the tests will go through a less burdensome process to obtain marketing clearances.
The firm saw strong increases in international HIV sales of its OraQuick HIV Self-Test product in the quarter.
The clearance covers tests made by the firm's joint venture for manufacturing, CoSara Diagnostics, in its facility in Ranoli, India.
OraSure will purchase Houston-based Diversigen, a microbiome and metagenomics consulting, sequencing, and data analysis service provider.
The company said that the decline in revenues reflected lower industry-wide reimbursement rates under PAMA.
The SuperExtract 32 with the SuperExtract Viral Mag NA Purification kit provides high-quality purification of hepatitis and HIV viral nucleic acid.
The tests run on the firm's sample-to-result automated molecular diagnostics instruments designed for use by high-volume labs.
The firm said its new molecular platform, which offers random-access testing, high throughput, and a broad menu has the potential to replace multiple instruments in molecular labs.
Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.
Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.
The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.
This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.